Infusion of BCR/Abl Peptide-Reactive Donor T Cells to Achieve Molecular Remission of Chronic Myeloid Leukemia After CD34+ Selected Allogeneic Hematopoietic Cell Transplantation

Leukemia - United Kingdom
doi 10.1038/sj.leu.2404383

Related search